Novel bispecific nanobody mitigates experimental intestinal inflammation in mice by targeting TNF‐α and IL‐23p19 bioactivities.

Autor: Wang, Jiewen1 (AUTHOR), Kang, Guangbo1 (AUTHOR), Lu, Huiying2 (AUTHOR), de Marco, Ario3 (AUTHOR), Yuan, Haibin1 (AUTHOR), Feng, Zelin4 (AUTHOR), Gao, Mengxue1 (AUTHOR), Wang, Xiaoli4 (AUTHOR), Wang, Huahong5 (AUTHOR), Zhang, Xiaolan6 (AUTHOR), Wang, Yuli1,7,8 (AUTHOR), Zhang, Miao1,9 (AUTHOR), Wang, Ping10 (AUTHOR), Feng, Yuanhang1 (AUTHOR), Liu, Zhanju2 (AUTHOR) Liuzhanju88@126.com, Cao, Xiaocang4 (AUTHOR) doccaoxc@163.com, Huang, He1 (AUTHOR) huang@tju.edu.cn
Zdroj: Clinical & Translational Medicine. Mar2024, Vol. 14 Issue 3, p1-23. 23p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje